EXANE DERIVATIVES - ATRECA INC ownership

ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 98 filers reported holding ATRECA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ATRECA INC
ValueSharesWeighting
Q4 2020$130,292,000
+15.6%
8,0680.0%0.04%
+15.2%
Q3 2020$112,704,000
+24.0%
8,068
+88.9%
0.03%
+37.5%
Q2 2020$90,860,000
+28.6%
4,2700.0%0.02%
+20.0%
Q1 2020$70,665,0004,2700.02%
Other shareholders
ATRECA INC shareholders Q4 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,426,685$33,901,0002.42%
Samsara BioCapital, LLC 617,560$8,627,0002.41%
Aisling Capital Management LP 387,653$5,416,0001.73%
Board of Trustees of The Leland Stanford Junior University 205,248$2,867,0001.10%
Boxer Capital, LLC 2,202,333$30,767,0001.06%
Redmile Group, LLC 2,548,168$35,598,0000.65%
Vigilare Wealth Management 18,570$259,0000.27%
Maven Securities LTD 200,000$2,810,0000.23%
Castle Hook Partners LP 400,000$5,588,0000.22%
Sio Capital Management, LLC 78,768$1,100,0000.22%
View complete list of ATRECA INC shareholders